Phase 2B Upper Extremity Nerve Block Study

NCT03011333 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

243

Enrollment

INDUSTRY

Sponsor class

Conditions

Postoperative Pain

Interventions

DRUG: HTX-011
DRUG: Bupivacaine HCl without epinephrine
DRUG: Saline Placebo

Sponsor

Heron Therapeutics